Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Life Sciences|March 16, 2002
Interaction of digoxin with antihypertensive drugs via MDR1Kohji Takara, Mikio Kakumoto, Yusuke Tanigawara, et al.
Brain & Development|November 10, 2004
A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazamKenjiro Kosaki, Kazuyo Tamura, Reiko Sato, et al.
Biological & Pharmaceutical Bulletin|December 25, 2002
MDR1-mediated interaction of digoxin with antiarrhythmic or antianginal drugsMikio Kakumoto, Kohji Takara, Toshiyuki Sakaeda, et al.
American Journal of Ophthalmology|January 5, 2005
Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injectionMakoto Inoue, Kayoko Takeda, Kunihiko Morita, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 3, 2003
Comparison of the pharmacokinetics of S-1, an oral anticancer agent, in Western and Japanese patientsEmmanuelle Comets, Kazumasa Ikeda, Paulo Hoff, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2006
Population pharmacokinetics of Arbekacin in patients infected with methicillin-resistant Staphylococcus aureusYusuke Tanigawara, Reiko Sato, Kunihiko Morita, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 20, 2018
Application of PBPK Modeling and Virtual Clinical Study Approaches to Predict the Outcomes of CYP2D6 Genotype-Guided Dosing of TamoxifenToshimichi Nakamura, Kota Toshimoto, Wooin Lee, et al.
Hormone Research in Paediatrics|July 18, 2017
Population Pharmacokinetics of Diazoxide in Children with Hyperinsulinemic HypoglycemiaRika Kizu, Kazuko Nishimura, Reiko Sato, et al.
Japanese Journal of Clinical Oncology|April 28, 2009
A pharmacokinetic and dose escalation study of pegfilgrastim (KRN125) in lung cancer patients with chemotherapy-induced neutropeniaNobuyuki Yamamoto, Ikuo Sekine, Kazuhiko Nakagawa, et al.
Pageof 10